Australian Refundable Research & Development Credit (Details Textual)			3 Months Ended	6 Months Ended	12 Months Ended
Mar. 31, 2015 USD ($)	Dec. 31, 2014 USD ($)	Mar. 31, 2015 Lipimetix Australia Pty Ltd [Member] AUD	Jun. 30, 2014 Lipimetix Australia Pty Ltd [Member] AUD	Dec. 31, 2014 Lipimetix Australia Pty Ltd [Member] AUD	Mar. 31, 2015 Lipimetix Australia Pty Ltd [Member] USD ($)	Dec. 31, 2014 Lipimetix Australia Pty Ltd [Member] USD ($)
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent			45.00%
Research and Development Expense			205,000	227,000	242,000
Other Assets, Current	$ 631,000us-gaap_OtherAssetsCurrent	$ 555,000us-gaap_OtherAssetsCurrent	447,000		242,000	$ 340,000	$ 196,000

- Definition

The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.

+ References+ Details